Cargando…
Corrigendum to “XRRA1 Targets ATM/CHK1/2-Mediated DNA Repair in Colorectal Cancer”
Autores principales: | Wang, Wenjun, Guo, Minzhang, Xia, Xiaojun, Zhang, Chao, Zeng, Yuan, Wu, Sipei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935600/ https://www.ncbi.nlm.nih.gov/pubmed/33728327 http://dx.doi.org/10.1155/2021/3030267 |
Ejemplares similares
-
XRRA1 Targets ATM/CHK1/2-Mediated DNA Repair in Colorectal Cancer
por: Wang, Wenjun, et al.
Publicado: (2017) -
The Combination of ATM and Chk1 Inhibitors Induces Synthetic Lethality in Colorectal Cancer Cells
por: Tozaki, Yuri, et al.
Publicado: (2023) -
ATM-mediated stabilization of ZEB1 promotes DNA damage response and
radioresistance through CHK1
por: Zhang, Peijing, et al.
Publicado: (2014) -
Trial Watch: Targeting ATM–CHK2 and ATR–CHK1 pathways for anticancer therapy
por: Manic, Gwenola, et al.
Publicado: (2015) -
Corrigendum to “Claudin-1 Is a Valuable Prognostic Biomarker in Colorectal Cancer: A Meta-Analysis”
por: Zuo, Didi, et al.
Publicado: (2020)